Medicon Village Investor Panel (MVIP)

 

Medicon Village Investor Panel (MVIP) is a strategic initiative designed to strengthen the financial ecosystem for life science companies by connecting them with crucial capital and expert investor support. This program will connect Medicon Village companies with a curated panel of experienced investors to help accelerate growth and innovation in the life science sector.

Led by corporate finance expert Markus Neuding, MVIP offers a unique opportunity for companies to pitch their businesses to a distinguished panel of investors with diverse backgrounds in life science funding. By bringing together professionals with diverse experience in life science funding, MVIP will provide access to new capital and unlock valuable expertise, strategic insights, and networking opportunities essential for growth and success in this complex sector. Read more about the panel of investors for the 2026 edition.

Why participate in MVIP?

• Access fresh capital: Secure essential funding to drive your company’s development.
• Gain strategic insight: Receive critical, constructive feedback from experienced investors.
• Expand your network: Connect with industry experts and build relationships that support your board and business strategy.

Companies who apply to join this year’s MVIP programme will be subject to eligibility requirements, including sector relevance, stage of development, and overall investment readiness. Medicon Village member companies will be prioritised, and members who are admitted into this year’s programme will be able to participate at no cost. Companies who are not members at Medicon Village are welcome to apply, and will be subject to the same eligibility requirements, as well as an entry fee of SEK 49 000 excluding VAT upon acceptance.

For any inquiries, please reach out to:

• Markus Neuding: markus.neuding@sedermera.se
• Sarah Lidé: sarah.lide@mediconvillage.se
• Francesco Bez: francesco.bez@mediconvillage.se

---

Previous edition of MVIP in 2025

The inaugural 2025 edition featured an extraordinary lineup of investors who gathered for a full day, closed door session in October 2025. Read more about the selected companies or download the MVIP booklet to find out more.

Testimonials from participating companies

“One of the best pitching events I have ever been a part of.”
Per Norlen, CEO, Strike Pharma

”MVIP is a great concept. You have truly reinvented the pitch format in such a way that lends to deeper and much more valuable interactions with investors.”
Cathrin Johansson, CEO, MedVasc